期刊文献+

国内外非酒精性脂肪性肝病诊疗指南的异同及解读 被引量:9

Understanding and explanation on Chinese and overseas guidelines of the diagnosis and treatment in the nonalcoholic fatty liver disease.
原文传递
导出
摘要 为规范非酒精性脂肪性肝病(NAFLD)的诊治与疗效评估,中华医学会肝病学分会脂肪肝和酒精性肝病学组按照循证医学的原则,于2006年5月制定了《非酒精性脂肪性肝病诊疗指南》。与国际上发表的指南或共识相比,较为全面和广泛地反映了目前NAFLD的临床诊疗现状,尽管彼此类似,但在诊治规范上也存在差异,本文就国内外NAFLD诊疗指南的异同进行解读。 Evidence-based guideline of the diagnosis and treatment in the nonalcoholic fatty liver disease was formulated by Chinese Medical Association of fatty liver disease and alcoholic liver disease in order to simplify medical decision making and to help physicians make good decisions about NAFLD, which was published in 2006. Compared with some international guidelines or recommendations, Chinese guideline is more wide and complete for diagnosis and therapy of NAFLD. Meanwhile, there is significant difference in evaluation and treatment between these guidelines.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2009年第5期410-412,共3页 Chinese Journal of Practical Internal Medicine
  • 相关文献

参考文献7

二级参考文献23

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1596

同被引文献93

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部